StonvexLoading…
StonvexStonvexStonvexCore line items from VRRM's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $979.08M | $879.21M | $817.31M | $741.60M |
Operating Income | $238.41M | $136.02M | $188.81M | $164.71M |
Net Income | $136.63M | $31.45M | $57.02M | $92.47M |
EPS (Diluted) | $0.85 | $0.19 | $0.36 | $0.50 |
Total Assets | $1.65B | $1.61B | $1.79B | $1.76B |
Total Liabilities | $1.35B | $1.35B | $1.37B | $1.53B |
Cash & Equivalents | $65.27M | $77.56M | $136.31M | $105.20M |
Free Cash Flow OCF − CapEx | $136.71M | $152.79M | $149.12M | $170.15M |
Shares Outstanding | 153.56M | 159.59M | 166.56M | 148.96M |